A Novel High-Speed Method for Single-Base DNA Methylation Detection and Quantification
Our Luna Labs’ biotech team has developed a faster, simpler way to detect epigenetic changes related to post-traumatic stress disorder (PTSD), reducing DNA methylation identification from 4 days (using standard approaches) to 9 hours. This breakthrough method, funded by the Department of Defense SBIR program and published in ACS Pharmacology & Translational Science, removes many of the complex and time-consuming steps previously needed.
Luna Labs’ EpiNanoSPRiᵀᴹ technology involves a simple yet highly sensitive blood test to identify epigenetic modifications associated with PTSD. Our technology:
– Identifies DNA methylation patterns associated with PTSD
– Reduces analysis time from 4 days to just 9 hours
– Detects methylation at the single-base level
– Simultaneously analyzes multiple PTSD-associated genes
This work is opening new doors for the assessment and treatment of PTSD as well as new possibilities for the diagnosis of traumatic brain injury, dementia, and Alzheimer’s, Parkinson’s, and Huntington’s diseases.
Read the white paper here.
Luna Labs is interested in partnerships and collaborative research and development.
Reach out to let us know about your interests.
Categories
Tags
Share:
More Articles
-
Rapid Detection of PTSD-Associated DNA Methylation
Our EpiNanoSPRi technology is a simpler way to detect epigenetic modifications related to PTSD, with the potential for faster diagnosis and treatment.
Categories
Tags
-
Insights and Inspiration: Forging the Commercial Path
What do innovation and commercialization look like at Luna Labs? Relentless determination and a whole lot of creativity. Discover more insights from our CCO, Drake Goolsby.
Categories
-
Breaking New Ground in Vaccine Development
We're pleased to share insights from our recent interview with our collaborator, Dr. Moriya Tsuji, who discusses strategies for enhancing T cell responses for advanced vaccine development.
Categories
Tags